Skip to main navigation Skip to search Skip to main content

A Randomized, Placebo Surgery Controlled, Double Blinded, Multi-center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of VY-AADC02 in Advanced Parkinson's disease with Motor Fluctuations (ADAPT)

Project: Research

Project Details

StatusActive
Effective start/end date01/1/2107/31/26

Funding

  • IQVIA Incorporated: $9,750.00